Equities

Greenlight Capital Re Ltd

Greenlight Capital Re Ltd

Actions
FinancialsNon-life Insurance
  • Price (USD)14.79
  • Today's Change0.03 / 0.20%
  • Shares traded48.19k
  • 1 Year change+36.57%
  • Beta0.8748
Data delayed at least 15 minutes, as of Nov 11 2024 18:17 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Greenlight Capital Re, Ltd. provides multiline property and casualty insurance and reinsurance through its licensed and regulated reinsurance entities in the Cayman Islands and Ireland, and its Lloyd’s platform, Greenlight Innovation Syndicate 3456. Its property business covers personal lines, commercial lines exposures and automobile physical damage. The property business includes both catastrophe and non-catastrophe coverage. Its casualty business covers general liability, motor liability, professional liability, and workers compensation exposures. The Company’s multi-line business includes the Funds at Lloyd’s business. Its other business covers accident and health, financial (including transactional liability, mortgage insurance, surety, and trade credit), marine, energy, as well as other specialty business, such as aviation, crop, cyber, political, and terrorism exposures. Its subsidiaries include Greenlight Reinsurance, Ltd., Greenlight Re Marketing (UK) Limited, and others.

  • Revenue in USD (TTM)667.40m
  • Net income in USD87.84m
  • Incorporated2004
  • Employees64.00
  • Location
    Greenlight Capital Re LtdCAMANA BAY65 MARKET STREET, SUITE 1207,P.O. Box 31110GRAND CAYMAN KY1-1205Cayman IslandsCYM
  • Phone+1 3 459434573
  • Fax+1 3 457454576
  • Websitehttps://greenlightre.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Zhibao Technology Inc19.80m-6.00m115.38m148.00--22.00--5.83-0.228-0.2280.75160.1664------133,754.20--------41.25---30.33-----48.830.467--31.30---402.25------
Partnerre Ltd9.12bn2.31bn132.24m1.25k0.71610.19640.05670.014523.0823.0891.2384.240.3153----7,309,965.008.062.37--------25.578.46--39.370.182718.1059.3010.29343.11------
eHealth Inc464.89m-78.96m155.85m1.90k--0.3135--0.3352-2.66-2.6616.0227.980.4584--2.23244,293.80-3.47-2.26-3.67-2.4753.0399.51-7.58-4.38---1.040.0772--11.7212.4944.30---0.0907--
Maiden Holdings Ltd82.74m-32.82m188.57m45.00--0.7925--2.28-0.326-0.3260.8222.380.054----1,838,622.00-2.48-1.10---------45.91-15.41---3.210.51690.0037.85-47.89-169.98------
GoHealth Inc700.20m-62.15m272.01m2.47k--1.34--0.3885-6.39-6.3972.2511.110.5112--28.32283,598.20-10.16-14.53-14.21-22.1980.6175.17-19.87-31.21---0.75640.5447--16.3126.5757.46--17.35--
Aspen Insurance Holdings Ltd3.00bn441.60m292.66m946.003.640.7592--0.09757.317.3149.7047.520.1944------3.220.4632--------16.542.34--12.310.094680.877.294.277,358.46---20.08--
SelectQuote Inc1.38bn-47.62m408.18m1.34k--1.51--0.2955-0.2804-0.28048.121.571.19--12.831,034,689.00-4.11-3.20-4.73-3.5444.8052.59-3.45-4.09--0.92060.7164--31.8031.4041.71--6.20--
TWFG Inc187.28m26.37m494.27m264.0016.666.5114.112.642.002.0014.235.13------709,397.80--------37.60--14.08----11.280.4155--12.35--8.20------
Greenlight Capital Re, Ltd.667.40m87.84m514.13m64.005.850.775--0.77042.522.5219.1719.050.3568----10,428,110.004.701.77--------13.164.73----0.08620.0018.6630.33242.63------
Crawford & Company1.30bn22.92m577.79m10.20k25.373.799.940.4450.46030.460326.223.091.62--4.68127,305.002.802.024.283.0628.1726.621.731.37--3.140.609771.646.963.24267.220.68764.045.39
Abacus Life Inc95.38m-5.90m673.36m102.00--2.61731.927.06-0.093-0.0931.483.450.2506--13.94935,095.70-1.56---1.72--89.00---6.23----1.350.4342--48.50---69.96------
Data as of Nov 11 2024. Currency figures normalised to Greenlight Capital Re Ltd's reporting currency: US Dollar USD

Institutional shareholders

31.85%Per cent of shares held by top holders
HolderShares% Held
Dimensional Fund Advisors LPas of 30 Sep 20242.00m5.67%
BlackRock Fund Advisorsas of 30 Jun 20241.93m5.46%
Morgan Stanley & Co. LLCas of 30 Jun 20241.43m4.04%
The Vanguard Group, Inc.as of 30 Jun 20241.33m3.76%
Ninety One UK Ltd.as of 30 Jun 20241.01m2.86%
Orchard Capital Management LLCas of 30 Jun 2024891.37k2.52%
Private Management Group, Inc.as of 30 Sep 2024793.54k2.25%
Punch & Associates Investment Management, Inc.as of 30 Jun 2024675.78k1.91%
Geode Capital Management LLCas of 30 Jun 2024625.83k1.77%
SSgA Funds Management, Inc.as of 30 Jun 2024569.61k1.61%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.